Home > Insider Trading > Filing (0001213900-24-077795)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1553643	Relmada Therapeutics Inc.	RLMD	Pharmaceutical Preparations (2834)	455401931

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1565832	Sergio Traversa	C/O Relmada Therapeutics, Inc. 2222 Ponce De Leon Blvd, 3Rd Floor Coral Gables FL 33134	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-09-09	55,579	$2.71	299,603	No	4	P	Direct
Common Stock	Acquisiton	2024-09-10	33,014	$2.75	332,617	No	4	P	Direct
Common Stock	Acquisiton	2024-09-11	51,407	$2.99	384,024	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
Purchase prices range from $2.51 to $2.85 per share, inclusive.
Purchase prices range from $2.73 to $2.80 per share, inclusive.
Purchase prices range from $2.84 to $3.05 per share, inclusive.